IL1B and hepatocellular carcinoma: Wei et al. (22) demonstrated that hepatocellular carcinoma (HCC) progression was associated with the deregulated expression of NLRP3 inflammasome components (including ASC, caspase-1, and IL-1β), and the NLRP3 inflammasome played a protective role in HCC.